Sutro Biopharma

STRONasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$151.966 M

$9.17 -7.80%

Close of 6 Nov 2026

As of 6 Nov 2026, Sutro Biopharma (STRO) has a market capitalization of $152.0M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$102.5M

#2476 by revenue

Earnings

-$191.0M

Loss-making

Shares outstanding

16,581,171

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →

#99InvivydIVVD$171.6M
#100Innate PharmaIPHA$156.4M
#101Sutro BiopharmaSTRO$152.0M
#102Protara TherapeuticsTARA$125.9M
#103Compass TherapeuticsCMPX$125.1M

What if Sutro Biopharma were worth as much as…

Open the what-if tool →

Gold $28.2T

$1,702,948

Per share 185,810× higher

Bitcoin $1.53T

$92,143.56

Per share 10,054× higher

Apple $5.02T

$302,498.70

Per share 33,006× higher

Or at a round number

$200.0M $500.0M $1.00B $2.00B

Where these numbers come from

Share counts and financials for Sutro Biopharma are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.